KRAS and neoplasm: We report here the results of the long-term follow-up of our phase II study8, with three-year survival results, together with findings from an analysis conducted to investigate any relationship between survival and baseline patient and disease characteristics, including tumour KRAS mutation status, and the type of surgery conducted.